Prescription drug · ANDA
Pioglitazone HCL and Metformin HCL NDC 13668-280
Metformin hydrochloride 500 mg/1; Pioglitazone hydrochloride 15 mg/1 · Tablet · Oral · Torrent Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 13668-280-05 | 1366802800513668028005 | 500 TABLET in 1 BOTTLE (13668-280-05)Marketed from Sep 1, 2025 | |
| 13668-280-10 | 1366802801013668028010 | 1000 TABLET in 1 BOTTLE (13668-280-10)Marketed from Sep 1, 2025 | |
| 13668-280-33 | 1366802803313668028033 | 180 TABLET in 1 BOTTLE (13668-280-33)Marketed from Sep 1, 2025 | |
| 13668-280-60 | 1366802806013668028060 | 60 TABLET in 1 BOTTLE (13668-280-60)Marketed from Sep 1, 2025 | |
| 13668-280-74 | 1366802807413668028074 | 100 TABLET in 1 CARTON (13668-280-74)Marketed from Sep 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pioglitazone HCL and Metformin HCL
- Generic name (nonproprietary)
- pioglitazone hcl and metformin hcl
- Active ingredients
- Metformin hydrochloride — 500 mg/1Pioglitazone hydrochloride — 15 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Torrent Pharmaceuticals LimitedNDC labeler code 13668
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202001
- Marketing start
- Listing expires
- Other FDA classes
- Biguanides (Chemical structure)Peroxisome Proliferator-activated Receptor alpha Agonists (Mechanism)Peroxisome Proliferator-activated Receptor gamma Agonists (Mechanism)Thiazolidinediones (Chemical structure)
- Identifiers
- Product ID 13668-280_05c4925c-a14b-4229-81b0-abb0f5f3814cSPL ID 05c4925c-a14b-4229-81b0-abb0f5f3814cSPL set ID 237d8fa2-633c-4c29-84d3-f1b413610dc3RxCUI 861783, 861822UNII 786Z46389E, JQT35NPK6CUPC 0313668280609, 0313668281606
- Pharmacologic class
- Biguanide; Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N413668028005followed by a unit qualifier and the quantityPackage 13668-0280-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Pioglitazone and metformin hydrochloride tablets, are a combination of pioglitazone, a thiazolidinedione agonist of peroxisome proliferator receptor gamma, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: Not recommended for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 ) Pioglitazone and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Pioglitazone and metformin hydrochloride tablets are not recommended to treat type 1 diab…
Excerpt only. Read the full label for complete information.
About NDC 13668-280
- What is NDC 13668-280?
- 13668-280 is the product NDC for Pioglitazone HCL and Metformin HCL, Metformin hydrochloride 500 mg/1; Pioglitazone hydrochloride 15 mg/1 tablet, listed with the FDA by Torrent Pharmaceuticals Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Pioglitazone HCL and Metformin HCL.
- What is the active ingredient?
- Metformin hydrochloride, Pioglitazone hydrochloride.
- Who is the labeler?
- Torrent Pharmaceuticals Limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Pioglitazone HCL and Metformin HCL?
- 1 other product NDC are listed under this name. See all Pioglitazone HCL and Metformin HCL NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Pioglitazone HCL and Metformin HCL products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Pioglitazone HCL and Metformin HCL | Metformin hydrochloride 850 mg/1; Pioglitazone hydrochloride 15 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | 13668-281 | 13668-0281-0513668-0281-3313668-0281-49+2 more |
Other NDCs under ANDA 202001
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pioglitazone HCL and Metformin HCL | Metformin hydrochloride 850 mg/1; Pioglitazone hydrochloride 15 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | 13668-281 |